Arteriotomy Closure Devices Market: Market Size & Forecast 2026

Arteriotomy closure devices are specialized medical tools designed to achieve hemostasis at arterial access sites following endovascular procedures. These devices reduce complications, procedure times, and patient recovery periods compared to manual compression techniques. The market encompasses various device types including mechanical clips, suture-based closures, and passive and active bioabsorbable sealants.

• •Market valued at approximately $1.57 billion in 2025 with projections to nearly double by the early 2030s
• •Primary applications include cardiac catheterization, angiography, and transcatheter aortic valve replacement procedures
• •Devices categorized by mechanism: mechanical, suture-mediated, and sealant-based technologies

The increasing global burden of cardiovascular diseases, including coronary artery disease and peripheral artery disease, is driving higher volumes of interventional procedures requiring arterial access. Technological innovations producing more effective, easier-to-use, and complication-reducing devices are expanding adoption rates among healthcare providers. Additionally, growing healthcare expenditure, favorable reimbursement policies in major markets, and training programs for interventional cardiologists are accelerating market expansion.

• •Rising prevalence of cardiovascular conditions demanding more diagnostic and interventional procedures
• •Advantages over manual compression including reduced bleeding complications and shorter hospital stays
• •Growing preference for minimally invasive techniques across both developed and developing healthcare systems

The market is segmented by device type, including active mechanical devices, passive mechanical devices, and bioabsorbable sealant-based closures. Geographically, North America currently represents the largest market share due to advanced healthcare infrastructure, high procedure volumes, and early adoption of innovative technologies. The Asia-Pacific region is expected to exhibit the fastest growth rate, fueled by improving medical facilities, rising disease burden, and increasing procedural volumes in countries such as China and India.

• •North America leads in market share, with Europe representing the second-largest regional market
• •Asia-Pacific emerging as the fastest-growing region due to expanding healthcare access and rising procedural volumes
• •Active devices segment commanding significant share due to superior efficacy and safety profiles

What are the recent trends and outlook?

The market is witnessing a shift toward more advanced bioabsorbable and hybrid closure technologies that minimize foreign body retention and improve long-term patient outcomes. Integration with other vascular access products and development of universally compatible devices are emerging focal points for manufacturers. As interventional procedures continue to migrate toward outpatient settings, demand for rapid, reliable closure solutions is expected to sustain robust market growth through the coming decade.

• •Growing emphasis on bioabsorbable sealant technologies that eliminate long-term implant complications
• •Increasing procedural volumes in ambulatory surgical centers driving demand for simplified closure systems
• •Expected sustained growth trajectory as cardiovascular intervention rates continue rising globally